3 UK Penny Stocks With Market Caps Over £10M To Consider

In This Article:

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weaker trade data from China affecting global economic sentiment. Despite such fluctuations, investors often look for opportunities in smaller or newer companies that may offer growth potential. Though the term 'penny stocks' might seem outdated, these stocks can still represent a valuable investment area when they exhibit strong financial foundations.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

Tristel (AIM:TSTL)

£3.70

£174.08M

★★★★★★

Foresight Group Holdings (LSE:FSG)

£3.80

£455.09M

★★★★★★

Polar Capital Holdings (AIM:POLR)

£4.905

£468.49M

★★★★★★

Begbies Traynor Group (AIM:BEG)

£0.918

£146.62M

★★★★★★

ME Group International (LSE:MEGP)

£2.185

£812.03M

★★★★★★

Helios Underwriting (AIM:HUW)

£2.23

£158.38M

★★★★★☆

Secure Trust Bank (LSE:STB)

£4.31

£81.05M

★★★★☆☆

Van Elle Holdings (AIM:VANL)

£0.38

£41.12M

★★★★★★

QinetiQ Group (LSE:QQ.)

£3.646

£2.03B

★★★★★☆

Stelrad Group (LSE:SRAD)

£1.435

£183.39M

★★★★★☆

Click here to see the full list of 444 stocks from our UK Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Cavendish

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Cavendish Financial plc, along with its subsidiaries, functions as an investment bank in the United Kingdom and has a market cap of £30.74 million.

Operations: The company generates £61.75 million in revenue from its Corporate Advisory and Broking, M&A Advisory, and Institutional Stockbroking services.

Market Cap: £30.74M

Cavendish plc, recently rebranded from Cavendish Financial plc, operates with a market cap of £30.74 million and generates revenue of £61.75 million through its investment banking services. Despite its revenue generation, the company remains unprofitable with declining earnings over the past five years at a rate of 48.7% annually. The board and management team are relatively new, averaging 1.4 years in tenure, which may affect strategic stability. Positively, Cavendish maintains more cash than total debt and has short-term assets exceeding both short- and long-term liabilities, suggesting financial resilience amidst operational challenges.

AIM:CAV Financial Position Analysis as at Feb 2025
AIM:CAV Financial Position Analysis as at Feb 2025

Provexis

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Provexis plc, with a market cap of £14.66 million, develops, licenses, and sells functional foods, medical foods, and dietary supplements globally.